OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer
Xinyan Jiang, Yan Cheng, Yanan He, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 3817-3826
Open Access | Times Cited: 7
Xinyan Jiang, Yan Cheng, Yanan He, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 3817-3826
Open Access | Times Cited: 7
Showing 7 citing articles:
MicroRNA as a Potential Therapeutic Molecule in Cancer
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Cells (2022) Vol. 11, Iss. 6, pp. 1008-1008
Open Access | Times Cited: 71
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Cells (2022) Vol. 11, Iss. 6, pp. 1008-1008
Open Access | Times Cited: 71
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 49
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 49
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
Meysam Moghbeli
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 48
Meysam Moghbeli
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 48
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma
Yanlin Song, Yuan Cheng, Tianxia Lan, et al.
Cancer Letters (2022) Vol. 554, pp. 216012-216012
Open Access | Times Cited: 5
Yanlin Song, Yuan Cheng, Tianxia Lan, et al.
Cancer Letters (2022) Vol. 554, pp. 216012-216012
Open Access | Times Cited: 5
A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway
Runhui Lu, Ying Zhang, Ran Chen, et al.
Neoplasia (2024) Vol. 59, pp. 101082-101082
Closed Access
Runhui Lu, Ying Zhang, Ran Chen, et al.
Neoplasia (2024) Vol. 59, pp. 101082-101082
Closed Access
Salidroside overcomes cisplatin resistance in ovarian cancer via the inhibition of CRNDE-mediated autophagy
Ge Yu, Abiyasi Nanding
Molecular and Cellular Biochemistry (2024)
Closed Access
Ge Yu, Abiyasi Nanding
Molecular and Cellular Biochemistry (2024)
Closed Access
KRT17 enhances carboplatin resistance in ovarian cancer through the AKT/mTOR pathway
Yu Cuixia, Yu Q, Jing Lu, et al.
European Journal of Gynaecological Oncology (2022)
Open Access | Times Cited: 3
Yu Cuixia, Yu Q, Jing Lu, et al.
European Journal of Gynaecological Oncology (2022)
Open Access | Times Cited: 3
